The study on the effectiveness of protease inhibitors for patients with refractory urticaria
Not Applicable
- Conditions
- urticaria
- Registration Number
- JPRN-UMIN000003445
- Lead Sponsor
- Department of Dermatology, Programs for Biomedical Research, Division of Molecular Medical Science, Graduate School of Biomedical Sciences, Hiroshima University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. Pregnant or lactating women or women of child bearing potential not using contraception 2. Patients with diseases as follows. Liver disease, psychological illness, convulsive and other seizure, heart disease, hemoglobinopathy, hemophilia, uncontrolled diabetes, and autoimmune diseases. 3. Patients who use medications that influence the coagulation and fibrinolytic cascade. 4. Patients who were administered nafamostat mesilate and camostat mesilate with serious adverse events. 5. Patients in contraindication of nafamostat mesilate and camostat mesilate. 6. Others who the physician judges are not suitable as subjects
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rticarial symptom scores before and after medications
- Secondary Outcome Measures
Name Time Method